Pharmacological interventions, particularly Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs), including Liraglutide and Semaglutide have emerged as a significant treatment option
Many sickness behaviors such as chills and goose pimples, assuming the fetal position to reduce body surface area, or wearing thick clothing and seeking warmer environments can be observed
Patients can also explore personalized treatment through the Precision Peptide Genetic Test ($99 add-on after first month), which maps 14 metabolic pathways and 49 peptides to identify how your genetics influence weight management and medication response
Second-generation: cilofexor (GS-9674), tropifexor (LJN452) Cilofexor is a potent, selective, nonsteroidal agonist of FXR that predominantly activates intestinal FXR without involvement of the enterohepatic circulation
At 8mg, that figure was approximately 71%
For someone with borderline-high LDL, this shift could move them from a risk category that warrants medication consideration to one that does not